current companies
- Filter:
- All
- #
- a
- b
- c
- d
- e
- f
- g
- h
- i
- j
- k
- l
- m
- n
- o
- p
- q
- r
- s
- t
- u
- v
- w
- x
- y
- z
Artful solutions to scientific challenges
3X Genetics
Screening the world's population for Myotonic Dystrophy and other trinucleotide repeat disorders.
AAVinue, Inc.
AAVinue, Inc. is a pre-seed stage biotech startup, pioneering development of advanced AAVs (adeno-associated viruses) capable of evading neutralizing antibodies and providing deep tissue penetration to allow increased patient access to life-saving therapies.
Advirna
Innovative solutions for oligonucleotide delivery.
Arogy Tx
CG Scientific
Novel technology for extracting mesenchymal stem cells.
Codomax
Codomax applies its Epi-MAX platform technology to re-engineer strains and expression vectors to enable maximal production of difficult-to-express biologics.
Conigen Bioscience
Conigen Bioscience Inc. is a life science tools company that integrates state-of-art immunology, virology, molecular biology and cell biology to create new reagents and high-quality assays for discovery, development, and manufacturing.
DermBiont
Leveraging skin microbiome therapeutics to treat, cure, and prevent skin diseases
EasyText.AI
Make web text so simple we understand it the first time we read it.
Enamel Pure
Healthy Enamel, Pure Smiles
Ethos Laboratories
Ethos is a CAP-accredited, CLIA-certified, high-complexity laboratory that specializes in the highest quality diagnostic testing including clinical toxicology, biomarker testing, pharmacogenetics, serology, and infectious disease testing.
Fornax Biotech
Next-generation sequencing, bioinformatics and RNA-related services.
Hessian Labs
Hessian Labs harnesses information from platelets, a highly responsive biological system, to build non-invasive tools with ‘next level’ diagnostic capability.
JURA Bio, Inc.
Building CAR-T to fight autoimmunity
Leal Therapeutics
A CNS-focused biotech start-up working to develop a pipeline of novel, ultra-precise therapeutics for major CNS indications.
LoopCO2
Experts of converting CO2 to plastics
Metro Biotech
First-in-class, small-molecule NAD+ enhancers to treat rare diseases and combat aging.
Microgradient Fluidics
Microfluidics for quantifying biomolecule stability and interactions
Neurotech Pharmaceuticals, Inc.
A long-term solution to slow disease progression, helping patients maintain vision and quality of life.
Non Human Primate Reagent Resource (NHPRR)
NHPRR supports innovation, reproducibility, and translation of preclinical research with high-quality biologics development
Pananosis
A platform blood-based diagnostic test powered by computationally analyzing immune footprint patterns
Prana Biosciences
Using innovation to reformulate existing drugs.
Prothia
Device specialists in cardiovascular, perinatal and rehabilitation applications.
Quantum Technology Group
Quantum's unique manufacturing process presents the ability to produce nontoxic quantum dots and deliver bulk manufacturing
SignaBlok, Inc.
Multi-Indication Cancer Platform Therapeutic
SpadXTech
SpadXTech seeks to significantly reduce CO2 emissions through the manufacturing of various carbon negative cellulose-based materials. Through its material platform technology and versatility, they can potentially impact the packaging, textiles, transportation, filtration, and the construction industries.
Spatial Surgical
Novel first in class orthopedic laser system that rapidly and safely ablates soft tissue and bone through a single handpiece
Splice Histology
Splice provide timely, high-quality, individual histopathology services when you need them.
Targeted Cell Therapies
Novel oral delivery treatment for Gaucher disease.
uBriGene
uBriGene Bioscience Inc. is a leading contract development and manufacturing organization (CDMO), specializing in the development and application of cell and gene therapy technologies.
Volta Energy
Volta Energy is developing next generation electrochemical energy storage technologies for renewable electricity including flow batteries and electrolyzers.
X Therapeutics
Startup developing a new generation of medicines against infectious diseases
ZATA Pharmaceuticals
Transforming blood transfusion through pathogen inactivation.